Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2Phase 4 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Urologic Neoplasms 1Urologic Diseases 1Prostatic Neoplasms 1Hypogonadism 1

Interventions

pembrolizumab 258Cyclophosphamide 247Specimen Handling 197fludarabine 176Magnetic Resonance Spectroscopy 171Biopsy 146Nivolumab 124Carboplatin 100Radiotherapy 92Paclitaxel 90venetoclax 82Cisplatin 82fludarabine phosphate 80Gemcitabine 79Injections 69Ipilimumab 65Dexamethasone 63atezolizumab 58Bevacizumab 58Fluorouracil 57Cetuximab 57Azacitidine 57Radiation 56durvalumab 55Radiosurgery 51Temozolomide 48Oxaliplatin 45Rituximab 44Irinotecan 44Docetaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Testosterone Propionate × 1 year × Clear all
NCT04731376 2026-05-26

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Emory University

Phase 1 Active not recruiting
56 enrolled
Genitourinary

Hypogonadism, Urologic Diseases, Urologic Neoplasms

NCT06305598 2026-05-15

Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer

Roswell Park Cancer Institute

Phase 1 Recruiting
14 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡